IDVOther than small business
IDC (multiple-award IDV) 75N91024D00005UNIVERSITY OF OKLAHOMA
Overview
Award facts
- Obligated on orders under this IDV
- $3.14M
- $3,142,485 across 3 orders
- Period of performance
- From Jan 25, 2024
- Modifications
- 5
- Latest action Jul 9, 2026
- Contract type
- IDC (multiple-award IDV)
- PIID 75N91024D00005
Description of requirement
PRECLINICAL EFFICACY & INTERMEDIATE ENDPOINT BIOMARKERS IDIQ CONTRACT IN SUPPORT OF THE PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM
Dates and value
- Award date
- Signed on Jan 24, 2024
- Ordering period ends
- Jan 24, 2029
- Ceiling
- Shared program ceiling (all awardees of this multiple-award vehicle, not a per-awardee value): $149,995,000
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jul 9, 2026. View on USAspending · Recipient on SAM.gov
Recipient
LocationOKLAHOMA CITY, OK
UEIGY8NMUZQXVS7
CAGE code4B862
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeUS government entity
Parent companyUNIVERSITY OF OKLAHOMA
Business types and certifications
Educational institutionU.S. government entity
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Funded by
- Department of Health and Human Services
- National Institutes Of Health
- NIH NCI
Classification and competition
Classification
- Product or service (PSC)
- AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH (research and development)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Negotiated proposal/quoteNP
- Set-aside
- No set-aside used
- Contract pricing
- Order dependent (IDV allows pricing arrangement to be determined separately for each order)1
- Offers received
- 9
Solicitation and notices
- Solicitation ID
- 75N91023R00024
- Solicitation date
- Jan 6, 2023
- Notices
- Solicitation posted Sep 16, 2024
- Award Notice posted Feb 1, 2024
- Award Notice posted Feb 1, 2024
- Award Notice posted Feb 1, 2024
- Award Notice posted Feb 1, 2024
- Solicitation posted Feb 23, 2023
- Solicitation posted Jan 31, 2023
- Solicitation posted Jan 6, 2023
- Presolicitation posted Dec 29, 2022
- Presolicitation posted Dec 19, 2022
Contract details
- Subcontracting plan
- Individual subcontract planF
- Major program
- Prevent cancer preclinical drug development program: preclinical efficacy and intermediate endpoint
- Cost Accounting Standards clause
- Yes - CAS clause includedY
- Certified cost or pricing data
- No
- Service Contract Act labor standards
- No
- Commercial procedures
- Commercial products/services procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Jan 24, 2024
- Latest action
- Jul 9, 2026 — Supplemental agreement (within scope)Modification P00005
- Latest substantive action
- Jul 9, 2026 — Supplemental agreement (within scope)Modification P00005
- Actions by type
- Base award1
- Supplemental agreement (within scope)4
- Other administrative action1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- Bio-basedE
- Clinger-Cohen Act planning (IT)
- No
- Walsh-Healey Act (materials and supplies)
- No
- Construction wage rates (Davis-Bacon)
- No
Place and origin
- Domestic or foreign entity
- Other U.S. entity (e.g. government)B
Structure
- Award or IDV
- IDV
- IDV type
- IDCB
- Indefinite-delivery contract type
- Indefinite delivery / indefinite quantityB
- Multiple or single award
- Multiple awardM
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7529
- Contracting office code
- 75N910
- Transactions recorded under this award key
- 2
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7529
- Funding office code
- 75N910